Date published: 
18 September 2018
Type: 
News
Intended audience: 
General public

The Australian Government is investing $10 million to fund six new rare cancer and rare disease clinical trials. 
The aim is to find new treatments and more support for Australians with a range of diseases with low survival rates and few effective treatments.
The six new clinical trials will target:

  • Pancreatic cancer
  • Traumatic brain injury
  • Rare skin tumours
  • Myeloma
  • Myelofibrosis
  • High mortality cancers, such as glioblastoma.

The clinical trials are funded by the Medical Research Future Fund. For more information read the media release.

The clinical trials are funded by the Medical Research Future Fund. For more information read the media release.